Charles Schwab Investment Management Inc Syndax Pharmaceuticals Inc Transaction History
Charles Schwab Investment Management Inc
- $557 Billion
- Q2 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 712,310 shares of SNDX stock, worth $11.1 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
712,310
Previous 689,693
3.28%
Holding current value
$11.1 Million
Previous $8.48 Million
21.26%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding SNDX
# of Institutions
251Shares Held
100MCall Options Held
1.28MPut Options Held
1.29M-
Kynam Capital Management, LP Princeton, NJ8.52MShares$133 Million9.53% of portfolio
-
Black Rock Inc. New York, NY7.91MShares$123 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY5.8MShares$90.3 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.03MShares$78.4 Million0.0% of portfolio
-
Eversept Partners, LP New York, NY4.07MShares$63.3 Million3.84% of portfolio
About Syndax Pharmaceuticals Inc
- Ticker SNDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,565,200
- Market Cap $881M
- Description
- Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...